证券记录 · 已归档季度
MMSI
Merit Medical Systems, Inc. · Healthcare · Medical - Instruments & Supplies
14被追踪持有人
—Δ持有人
5.63M持有股份
$483.63M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +2 | 41.26M | $2.86B | +12 | −9 |
| Q1 2026 | 119 | +2 | 38.80M | $2.68B | +10 | −9 |
| Q4 2025 | 117 | -1 | 45.00M | $3.97B | +2 | −2 |
| Q3 2025 | 21 | +1 | 28.60M | $2.38B | +1 | −1 |
| Q2 2025 | 18 | 0 | 26.61M | $2.49B | +1 | −1 |
| Q1 2025 | 15 | -1 | 7.60M | $802.99M | +1 | −2 |
| Q4 2024 | 16 | 0 | 7.36M | $712.26M | +2 | −2 |
| Q3 2024 | 15 | +1 | 4.73M | $467.42M | +1 | — |
| Q2 2024 | 14 | — | 5.63M | $483.63M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 1.34M | — | $115.18M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (被动) | 1.34M | — | $115.18M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Norges Bank ✦ (被动) | 782.73K | — | $67.28M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 780.48K | — | $67.08M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 780.48K | — | $67.08M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 634.61K | — | $54.54M | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 630.40K | — | $54.18M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 630.40K | — | $54.18M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 300.00K | — | $25.79M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 248.16K | — | $21.33M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 218.46K | — | $18.78M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 214.85K | — | $18.47M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 204.52K | — | $17.58M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 117.91K | — | $10.13M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 117.91K | — | $10.13M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 95.41K | — | $8.20M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 48.27K | — | $4.15M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 11.04K | — | $949,146 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 11.04K | — | $949,146 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 11.04K | — | $949,146 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 398 持有人, 58.87M 股份, $3.96B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 24
Peterson Neil W.
Officer · 7.50K 股 · $678,360
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据